Regulatory Consulting & Planning For Clinical Development Success

Regulatory planning for your clinical development program starts before and continues after you begin preparing your Investigational New Drug (IND) application. As you look to transition from lab to clinic, Veristat can help. Our regulatory, scientific and communications experts provide strategic regulatory planning, cross-functional operational support and the practical real-world knowledge of how to present your clinical and product development goals to the regulatory agencies.

Our teams have prepared regulatory strategies, developed clinical program designs and supported INDs for numerous programs to treat blood disorders, cancers, cardiovascular disease, endocrine disorders, genetic disorders, respiratory diseases, woman’s health issues and wound healing.